CJMB Overview

Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.

Wall Street analysts forecast CJMB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CJMB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Callan JMB Inc revenue for the last quarter amounts to 1.45M USD, increased 0.80

Callan JMB Inc. EPS for the last quarter amounts to -0.61 USD, increased 369.23

Callan JMB Inc (CJMB) has 10 emplpoyees as of March 09 2026.

Today CJMB has the market capitalization of 8.32M USD.